Table 1. Baseline characteristics of participants.
| Variables | Percentage |
|---|---|
| Females | 58.5 (n = 244) |
| Age, years, mean ± SD | 54.0 ± 11.6 |
| Duration of diabetes, years, mean ± SD | 13.4 ± 6.6 |
| Weight, kg, mean ± SD | 83.8 ± 16.6 |
| Medicine | |
| Insulin | 45.8 (n = 191) |
| Metformin | 89.9 (n = 375) |
| DPP-4 inhibitors | 52.7 (n = 220) |
| GLP-1 analogues | 39.0 (n = 163) |
| Sulphonylureas | 46.0 (n = 192) |
| TZDs | 8.6 (n = 36) |
| Laboratories | |
| HbA1c, mean ± SD | 8.3 ± 1.7 |
| Creatinine, mg/dL | 0.71 |
DPP-4: dipeptidyl peptidase-4; GLP-1: glucagon-like peptide-1; TZDs: thiazolidinediones; SD: standard deviation; . HbA1c: glycated hemoglobin